Internal Medicine, Endocrinology, Diabetes, & Metabolism · Boston, MA
NPI
1346230521
Since 2005
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
Zero Emerson Place, Ste 112 Neuroendocrine
Boston, MA, 02114
Phone (617) 726-7948
Groups this clinician bills Medicare through
Medicare paid, 2024
$19K
213 services
Medicare patients, 2024
131
Average age 70
Drug cost, 2024
$597K
798 prescriptions
Company payments, 2025
$5,928
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lisa B Nachtigall was code 99215 (office e&m - established), 115 times for 101 patients. In total Lisa B Nachtigall billed 213 services in 8 codes, and Medicare paid $19K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-11-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 115 | 101 | $108.41 | $12K |
| 99443 Telephone Services | Facility | 50 | 43 | $76.59 | $3,830 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 23 | 23 | $13.82 | $318 |
By year: 2022 $68K for 674 services; 2023 $21K for 214 services; 2024 $19K for 213 services.
Medicare prescription drug claims, 2024
In 2024, the drug Lisa B Nachtigall prescribed most often to Medicare patients was Levothyroxine Sodium, with 180 prescriptions and refills. In total Lisa B Nachtigall wrote 798 Medicare prescriptions that cost $597K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 180 | 521 | 57 | $1,879 |
| Testosterone Generic | 124 | 131 | 25 | $20K |
| Prednisone Generic | 96 | 259 | 30 | $1,341 |
| Cabergoline Generic | 76 | 198 | 21 | $12K |
| Hydrocortisone Generic | 41 | 115 | 13 | $2,178 |
| Synthroid Levothyroxine Sodium | 34 | 98 | Under 11 | $2,363 |
| Genotropin Somatropin | 32 | 33 | Under 11 | $75K |
| Testosterone Cypionate Generic | 28 | 30 | Under 11 | $689 |
| Vitamin D2 Ergocalciferol (Vitamin D2) | 21 | 36 | Under 11 | $153 |
| Mycapssa Octreotide Acetate | 18 | 18 | Under 11 | $228K |
| Somavert Pegvisomant | 17 | 17 | Under 11 | $169K |
| Desmopressin Acetate Generic | 16 | 34 | Under 11 | $450 |
| Alendronate Sodium Generic | 13 | 36 | Under 11 | $89.87 |
| Fludrocortisone Acetate Generic | 12 | 34 | Under 11 | $248 |
Brand drugs: - claims; generic drugs: 532 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Lisa B Nachtigall $5,928 ($5,928 in general payments such as food, travel and fees) from 2 companies. The largest payer was Chiesi USA, Inc. with $5,899.
| Company | Payments | Amount |
|---|---|---|
| Chiesi USA, Inc. | 3 | $5,899 |
| Astellas Pharma US Inc 4503.T | 1 | $28.44 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.